# Strategic Thinking - æˆ˜ç•¥æ€ç»´é¡¾é—®çŸ¥è¯†åº“
# ACS-Mentor V2.0 Core Module
# é«˜å±‹å»ºç“´çš„ç§‘ç ”è§†é‡ä¸é•¿æœŸè§„åˆ’

# ============================================================================
# Research Frontiers - ç ”ç©¶å‰æ²¿è¯†åˆ«
# ============================================================================

research_frontiers:

  description: "è¯†åˆ«å’Œè¯„ä¼°ç ”ç©¶å‰æ²¿è¶‹åŠ¿"

  # æ–°å…´æ–¹æ³•è¿½è¸ª
  emerging_methods:

    - name: "Causal Machine Learning"
      keywords: ["double ML", "causal forest", "targeted learning", "TMLE"]
      maturity: "early_adoption"
      impact_potential: 0.95
      learning_curve: "steep"

      description: |
        ç»“åˆæœºå™¨å­¦ä¹ çš„çµæ´»æ€§ä¸å› æœæ¨æ–­çš„ä¸¥è°¨æ€§

      key_papers:
        - "Chernozhukov et al. Double/debiased machine learning. Econometrics 2018"
        - "Wager & Athey. Estimation of heterogeneous treatment effects. JASA 2018"

      é€‚ç”¨åœºæ™¯:
        - "é«˜ç»´æ··æ‚æ§åˆ¶"
        - "å¼‚è´¨æ€§treatment effectä¼°è®¡"
        - "Non-linearå¤æ‚å…³ç³»"

      learning_resources:
        - "EconML library (Microsoft)"
        - "CausalML library (Uber)"

    - name: "Federated Learning in Healthcare"
      keywords: ["federated", "privacy-preserving", "distributed learning"]
      maturity: "emerging"
      impact_potential: 0.90
      learning_curve: "steep"

      description: |
        åœ¨ä¿æŠ¤éšç§çš„å‰æä¸‹ï¼Œè·¨æœºæ„åä½œå»ºæ¨¡

      advantages:
        - "æ— éœ€å…±äº«raw data"
        - "æ›´å¤§æ ·æœ¬é‡"
        - "GeneralizabilityéªŒè¯"

      challenges:
        - "æŠ€æœ¯å¤æ‚åº¦"
        - "æœºæ„åè°ƒæˆæœ¬"
        - "Regulatory hurdles"

    - name: "Real-World Evidence (RWE)"
      keywords: ["RWE", "pragmatic trial", "EHR-based", "observational"]
      maturity: "mainstream"
      impact_potential: 0.85
      learning_curve: "moderate"

      description: |
        åˆ©ç”¨çœŸå®ä¸–ç•Œæ•°æ®å›ç­”å®é™…ä¸´åºŠé—®é¢˜

      data_sources:
        - "EHR (ç”µå­ç—…å†)"
        - "Claims data (åŒ»ä¿æ•°æ®)"
        - "Registry (ç™»è®°æ³¨å†Œæ•°æ®)"
        - "Wearables (å¯ç©¿æˆ´è®¾å¤‡)"

      regulatory_acceptance:
        - "FDA: RWEæ¡†æ¶ (2018)"
        - "EMA: æ”¯æŒRWEç”¨äºregulatory decision"

      key_challenges:
        - "Data quality"
        - "Selection bias"
        - "Confounding control"

    - name: "Target Trial Emulation"
      keywords: ["target trial", "causal roadmap", "observational RCT"]
      maturity: "growing"
      impact_potential: 0.88
      learning_curve: "moderate"

      description: |
        ç”¨è§‚å¯Ÿæ€§æ•°æ®æ¨¡æ‹Ÿç†æƒ³çš„RCT

      framework:
        - "æ˜ç¡®å‡æƒ³çš„RCT protocol"
        - "Eligibility criteria"
        - "Treatment strategies"
        - "Assignment procedures"
        - "Follow-up period"
        - "Outcomes"
        - "Causal contrasts"

      reference: "HernÃ¡n & Robins. Using Big Data to Emulate a Target Trial. Epidemiology 2016"

  # çƒ­ç‚¹è¯é¢˜è¿½è¸ª
  hot_topics:

    - topic: "AI in Clinical Decision Support"
      peak_years: "2023-2026"
      saturation_risk: "high"
      current_gap: "Interpretability & Clinical validation"

      differentiation_strategies:
        - "Focus on interpretable AI (vs. black-box)"
        - "Rigorous external validation"
        - "Clinical utility assessment (decision curve analysis)"
        - "Implementation scienceè§’åº¦"

      caution: |
        é¿å…ï¼š
        - çº¯æŠ€æœ¯é©±åŠ¨ï¼ˆç¼ºå°‘ä¸´åºŠé—®é¢˜ï¼‰
        - åªåœ¨å•ä¸­å¿ƒæ•°æ®è®­ç»ƒ
        - å¿½è§†algorithm bias

    - topic: "Precision Medicine & Biomarkers"
      peak_years: "2020-2024"
      saturation_risk: "very_high"
      current_gap: "Translation to practice"

      differentiation_strategies:
        - "Focus on understudied populations"
        - "Novel biomarker discovery (multi-omics)"
        - "Cost-effectiveness analysis"
        - "Implementation barriersç ”ç©¶"

      realistic_expectation: |
        Precision medicineçš„promiseå¾ˆå¤§,ä½†translationå¾ˆæ…¢ã€‚
        é€‰æ‹©è¿™ä¸ªæ–¹å‘éœ€è¦:
        - Long-term commitment
        - è·¨å­¦ç§‘collaboration
        - Realistic timeline (5-10å¹´)

    - topic: "COVID-19 Long-term Effects"
      peak_years: "2021-2025"
      saturation_risk: "medium"
      current_gap: "Mechanisms & Treatment"

      opportunities:
        - "é•¿æœŸfollow-upæ•°æ®ç§¯ç´¯"
        - "Different variantsæ¯”è¾ƒ"
        - "Vaccination impact"
        - "Therapeutic trials"

    - topic: "Health Equity & Social Determinants"
      peak_years: "2020-ongoing"
      saturation_risk: "low"
      current_gap: "Intervention effectiveness"

      why_important:
        - "Persistent health disparities"
        - "Funding priority (NIH, foundations)"
        - "Policy relevance"

      differentiation_strategies:
        - "ä»descriptive â†’ intervention"
        - "Multilevel analysis"
        - "Community-engaged research"

# ============================================================================
# Gap Identification Framework - ç ”ç©¶Gapè¯†åˆ«æ¡†æ¶
# ============================================================================

gap_identification:

  types:

    methodological_gap:
      description: "ç°æœ‰æ–¹æ³•çš„å±€é™æ€§"

      examples:
        - "å¤–éƒ¨éªŒè¯ç¼ºå¤±"
        - "é•¿æœŸoutcomesæœªç ”ç©¶"
        - "ç‰¹å®šäººç¾¤underrepresented"
        - "Real-world effectivenessæœªçŸ¥"

      detection_questions:
        - "ç°æœ‰ç ”ç©¶ç”¨çš„æ˜¯ä»€ä¹ˆæ–¹æ³•ï¼Ÿ"
        - "è¿™äº›æ–¹æ³•æœ‰ä»€ä¹ˆå±€é™ï¼Ÿ"
        - "æœ‰æ²¡æœ‰æ›´å¥½çš„æ–¹æ³•å¯ä»¥ç”¨ï¼Ÿ"
        - "æ–°æ•°æ®æºèƒ½å¦å¡«è¡¥gapï¼Ÿ"

      å¡«è¡¥ç­–ç•¥:
        upgrade_method:
          example: "ç°æœ‰ç ”ç©¶ç”¨logisticï¼Œä½ ç”¨causal ML"
          value: "æ›´robustçš„ç»“æœ"

        external_validation:
          example: "å¤§é‡prediction modelsç¼ºå°‘external validation"
          value: "æå‡å¯ä¿¡åº¦å’Œgeneralizability"

        long_term_followup:
          example: "çŸ­æœŸç–—æ•ˆå·²çŸ¥ï¼Œé•¿æœŸunknown"
          value: "å›ç­”clinical relevant question"

    empirical_gap:
      description: "æœªè¢«ç ”ç©¶çš„ç°è±¡æˆ–äººç¾¤"

      examples:
        - "Understudied populations (minorities, elderly, children)"
        - "Rare diseases"
        - "Novel interventions/exposures"
        - "Emerging outcomes"

      detection_questions:
        - "å“ªäº›äººç¾¤/å¹²é¢„/ç»“å±€æœªè¢«ç ”ç©¶ï¼Ÿ"
        - "ä¸ºä»€ä¹ˆæ²¡äººç ”ç©¶ï¼Ÿ(feasibility? interest?)"
        - "æœ‰æ²¡æœ‰æ–°çš„æ•°æ®æºå¯ä»¥åˆ©ç”¨ï¼Ÿ"

      opportunity_assessment:
        check_data_availability:
          - "æ˜¯å¦æœ‰ç°æˆæ•°æ®ï¼Ÿ"
          - "æ•°æ®è´¨é‡å¦‚ä½•ï¼Ÿ"
          - "æ ·æœ¬é‡è¶³å¤Ÿå—ï¼Ÿ"

        check_significance:
          - "è¿™ä¸ªgapé‡è¦å—ï¼Ÿ"
          - "å¡«è¡¥åçš„impactï¼Ÿ"

        check_feasibility:
          - "ç ”ç©¶æˆæœ¬ï¼Ÿ"
          - "æ—¶é—´å‘¨æœŸï¼Ÿ"
          - "éœ€è¦çš„expertiseï¼Ÿ"

    theoretical_gap:
      description: "ç¼ºå°‘ç†è®ºè§£é‡Šæˆ–æœºåˆ¶ç ”ç©¶"

      examples:
        - "å·²çŸ¥å…³è”ï¼Œä½†æœºåˆ¶ä¸æ¸…"
        - "çŸ›ç›¾ç»“æœï¼Œç¼ºä¹reconciliation"
        - "Empiricalå‘ç°ï¼Œæ— ç†è®ºæ¡†æ¶"

      value_proposition: |
        æœºåˆ¶ç ”ç©¶çš„ä»·å€¼ï¼š
        1. å¢å¼ºå› æœå¯ä¿¡åº¦
        2. æŒ‡å¯¼interventionè®¾è®¡
        3. è¯†åˆ«é«˜å±äººç¾¤
        4. ç†è®ºè´¡çŒ®

      approaches:
        - "Mediation analysis"
        - "Subgroup analysis (effect modification)"
        - "Biomarker studies"
        - "Animal/in vitro models (if applicable)"

  # Gapè¯†åˆ«å·¥å…·ç®±
  toolkit:

    literature_review_strategy:
      step_1: "æ‰¾æœ€æ–°çš„systematic review/meta-analysis"
      step_2: "é‡ç‚¹è¯»'Limitations'å’Œ'Future research'éƒ¨åˆ†"
      step_3: "åˆ¶ä½œè¡¨æ ¼å¯¹æ¯”ç°æœ‰ç ”ç©¶çš„è®¾è®¡/äººç¾¤/æ–¹æ³•"
      step_4: "è¯†åˆ«patternï¼šwhat's consistently missing?"

    expert_consultation:
      who: "é¢†åŸŸèµ„æ·±ç ”ç©¶è€…ã€ä¸´åºŠä¸“å®¶"
      what_to_ask:
        - "What questions keep you up at night?"
        - "What would you do if you had unlimited resources?"
        - "What are the controversies in the field?"

    data_driven_discovery:
      approach: "åˆ©ç”¨ç°æœ‰å¤§å‹æ•°æ®åº“æ¢ç´¢æœªå›ç­”çš„é—®é¢˜"
      examples:
        - "UK Biobank: 50ä¸‡äººçš„rich phenotype data"
        - "Medicare claims: è¦†ç›–>6000ä¸‡è€å¹´äºº"
        - "MIMIC-III: ICUæ•°æ®"

# ============================================================================
# Innovation Assessment - åˆ›æ–°æ€§ä¸å½±å“åŠ›è¯„ä¼°
# ============================================================================

innovation_assessment:

  # åˆ›æ–°æ€§ç»´åº¦
  novelty_dimensions:

    - dimension: "Conceptual Novelty (æ¦‚å¿µåˆ›æ–°)"
      weight: 0.35

      levels:
        paradigm_shift: 1.0
        description: "æ”¹å˜é¢†åŸŸæ€ç»´æ–¹å¼"
        example: "ä»associationåˆ°causationçš„èŒƒå¼è½¬å˜"

        new_framework: 0.8
        description: "æå‡ºæ–°çš„ç†è®ºæ¡†æ¶"
        example: "Life course epidemiologyæ¡†æ¶"

        novel_hypothesis: 0.6
        description: "æ–°çš„ç ”ç©¶å‡è®¾"
        example: "åç›´è§‰çš„hypothesis"

        new_application: 0.4
        description: "å·²æœ‰æ¦‚å¿µçš„æ–°åº”ç”¨"
        example: "å°†Aé¢†åŸŸæ¦‚å¿µåº”ç”¨åˆ°Bé¢†åŸŸ"

    - dimension: "Methodological Novelty (æ–¹æ³•åˆ›æ–°)"
      weight: 0.30

      levels:
        new_method_development: 1.0
        description: "å¼€å‘æ–°ç»Ÿè®¡/åˆ†ææ–¹æ³•"
        example: "Double MLæ–¹æ³•"

        creative_application: 0.7
        description: "åˆ›é€ æ€§åº”ç”¨ç°æœ‰æ–¹æ³•"
        example: "Target trial emulation"

        methodological_improvement: 0.5
        description: "æ”¹è¿›ç°æœ‰æ–¹æ³•"
        example: "æ›´robustçš„IVæ–¹æ³•"

        overcome_limitation: 0.6
        description: "å…‹æœprevious technical barriers"
        example: "å¤„ç†high-dimensional confounding"

    - dimension: "Empirical Novelty (å®è¯åˆ›æ–°)"
      weight: 0.25

      levels:
        new_population: 0.7
        description: "åœ¨æ–°äººç¾¤ä¸­ç ”ç©¶"
        example: "First study in X population"

        novel_data_source: 0.8
        description: "åˆ©ç”¨æ–°æ•°æ®æº"
        example: "Wearables data, social media data"

        unprecedented_scale: 0.6
        description: "è§„æ¨¡ç©ºå‰"
        example: "First million-person study"

        long_term_followup: 0.5
        description: "å‰æ‰€æœªæœ‰çš„é•¿æœŸfollow-up"
        example: "30-year cohort"

    - dimension: "Clinical/Policy Impact (åº”ç”¨å½±å“)"
      weight: 0.10

      levels:
        practice_changing: 1.0
        description: "æ”¹å˜ä¸´åºŠå®è·µ"
        example: "Guideline-influencing"

        inform_policy: 0.8
        description: "å½±å“æ”¿ç­–åˆ¶å®š"

        tool_development: 0.6
        description: "å¼€å‘å®ç”¨å·¥å…·"
        example: "Risk calculator"

  # å½±å“åŠ›é¢„æµ‹æ¨¡å‹
  impact_prediction_model:

    factors:

      - factor: "Problem Importance"
        weight: 0.30

        indicators:
          disease_burden:
            metric: "DALYs, prevalence, mortality"
            high: ">1M DALYs globally"
            medium: "100K-1M DALYs"
            low: "<100K DALYs"

          unmet_need:
            assessment: "å½“å‰æ²»ç–—çš„limitations"
            high: "No effective treatment"
            medium: "Suboptimal treatment"
            low: "Adequate treatment available"

          controversy:
            value: "Controversial topics attract attention"
            example: "COVID-19, vaccine safety"

      - factor: "Methodological Rigor"
        weight: 0.25

        indicators:
          study_design_strength:
            - "RCT: highest"
            - "Quasi-experimental: high"
            - "Well-designed observational: medium"

          sample_size:
            - "Adequately powered: high"
            - "Marginally powered: medium"
            - "Underpowered: low"

          validation_quality:
            - "External validation: highest"
            - "Internal validation: medium"
            - "No validation: low"

      - factor: "Novelty & Innovation"
        weight: 0.25
        note: "Use novelty_dimensions scoring above"

      - factor: "Practical Feasibility"
        weight: 0.20

        indicators:
          implementation_cost:
            - "Low-cost intervention: high feasibility"
            - "Moderate cost: medium"
            - "High cost/complex: low"

          generalizability:
            - "Broadly applicable: high"
            - "Specific settings: medium"
            - "Limited applicability: low"

          stakeholder_acceptance:
            - "Aligned with stakeholder interests: high"
            - "Neutral: medium"
            - "Resistance expected: low"

    # è¯„åˆ†è§„åˆ™
    scoring:
      calculate: |
        impact_score = (
          problem_importance * 0.30 +
          methodological_rigor * 0.25 +
          novelty_innovation * 0.25 +
          practical_feasibility * 0.20
        )

      interpretation:
        high_impact: ">= 0.75"
        description: "Likely to be highly cited, practice-changing"

        moderate_impact: "0.50 - 0.75"
        description: "Solid contribution, incremental advance"

        incremental_impact: "< 0.50"
        description: "Incremental advance, limited reach"

# ============================================================================
# Strategic Planning - é•¿æœŸç ”ç©¶è§„åˆ’
# ============================================================================

strategic_planning:

  # èŒä¸šé˜¶æ®µç­–ç•¥
  career_stage_strategies:

    early_career:
      typical_profile: "PhD student, Postdoc, Junior faculty"
      focus: "å»ºç«‹æ ¸å¿ƒæ–¹æ³•å­¦èƒ½åŠ› & Track record"

      priorities:
        - priority: "Master 2-3 core statistical methods"
          why: "Method expertise is your competitive advantage"
          how: "Deep dive, not superficial knowledge"

        - priority: "Publish consistently"
          why: "Build track record for grants"
          target: "2-3 papers/year"

        - priority: "Develop reproducible workflow"
          why: "Efficiency & transparency"
          tools: "Git, R/Python, literate programming"

      project_selection_criteria:
        clear_contribution:
          rule: "èƒ½è¯´æ¸…'æˆ‘çš„ç‹¬ç‰¹è´¡çŒ®æ˜¯ä»€ä¹ˆ'"
          avoid: "Me-tooç ”ç©¶ï¼Œè¿‡åº¦crowdedé¢†åŸŸ"

        feasible_timeline:
          rule: "èƒ½åœ¨1-2å¹´å†…äº§å‡º"
          avoid: "5å¹´æ‰èƒ½å®Œæˆçš„mega-project"

        collaboration_potential:
          rule: "æœ‰mentorshipæˆ–collaborationæœºä¼š"
          value: "Learn from experienced researchers"

        skill_building:
          rule: "èƒ½å­¦åˆ°transferable skills"
          example: "New method, new data source"

      common_pitfalls:
        - pitfall: "Chasing hot topics without foundation"
          consequence: "Superficial work, outcompeted"

        - pitfall: "Too many side projects"
          consequence: "Nothingå®Œæˆ, scattered effort"

        - pitfall: "Perfectionism"
          consequence: "Never publish, slow progress"

    mid_career:
      typical_profile: "Associate Professor, Established researcher"
      focus: "å»ºç«‹ç ”ç©¶å“ç‰Œ & æ‰©å¤§å½±å“åŠ›"

      priorities:
        - priority: "Develop signature research line"
          why: "Known for something specific"
          how: "Series of related papers, programmatic research"

        - priority: "Lead multi-site collaborations"
          why: "Larger samples, generalizability"
          how: "Consortium, network research"

        - priority: "Mentor junior researchers"
          why: "Multiply your impact"
          how: "PhD students, postdocs"

        - priority: "Secure sustained funding"
          why: "Independence, resources"
          target: "R01-level or equivalent"

      project_selection_criteria:
        programmatic_coherence:
          rule: "Projects build on each other"
          benefit: "Cumulative expertise, brand building"

        high_impact_potential:
          rule: "Worth the effort investment"
          criterion: "Likely top-tier journal, practice-changing"

        resource_availability:
          rule: "Have funding & infrastructure"
          avoid: "Unfunded moonshot projects"

    established:
      typical_profile: "Full Professor, Leader"
      focus: "æ¨åŠ¨é¢†åŸŸå‘å±• & çŸ¥è¯†è½¬åŒ–"

      priorities:
        - priority: "Methodological innovation"
          why: "Shape how research is done"
          example: "Develop new methods, guidelines"

        - priority: "Guideline development"
          why: "Direct translation to practice"
          example: "Clinical practice guidelines"

        - priority: "Knowledge synthesis"
          why: "See the big picture"
          example: "Authoritative reviews, textbooks"

        - priority: "Train next generation"
          why: "Legacy"
          how: "PhD programs, workshops, online courses"

  # ç ”ç©¶ç»„åˆå¹³è¡¡
  research_portfolio_balance:

    rationale: |
      ä¸è¦æŠŠé¸¡è›‹æ”¾åœ¨ä¸€ä¸ªç¯®å­é‡Œã€‚
      å¹³è¡¡é£é™©ã€æ—¶é—´å‘¨æœŸã€åˆä½œæ¨¡å¼ã€‚

    dimensions:

      risk_profile:
        safe_projects: 0.50
        description: "ç¨³å¦¥å‡ºæˆæœçš„é¡¹ç›®"
        example: "Extension of previous work, established methods"
        purpose: "Maintain productivity, funding"

        moderate_risk: 0.30
        description: "æœ‰ä¸€å®šåˆ›æ–°ä½†é£é™©å¯æ§"
        example: "Novel application of known method"
        purpose: "Incremental innovation"

        high_risk_high_reward: 0.20
        description: "åˆ›æ–°æ€§å¼ºä½†æˆåŠŸä¸ç¡®å®š"
        example: "Method development, paradigm shift"
        purpose: "Breakthrough potential"

      time_horizon:
        short_term: 0.40
        definition: "<1å¹´å‡ºæˆæœ"
        example: "Secondary data analysis"
        purpose: "Maintain momentum, quick wins"

        medium_term: 0.40
        definition: "1-3å¹´"
        example: "Prospective cohort, multi-site study"
        purpose: "High-quality work"

        long_term: 0.20
        definition: ">3å¹´"
        example: "Long-term follow-up, complex intervention"
        purpose: "High-impact contribution"

      collaboration_mode:
        solo_or_small_team: 0.30
        advantage: "Full control, quick decision"
        disadvantage: "Limited resources"

        medium_collaboration: 0.50
        advantage: "Complementary expertise"
        example: "2-5 PIs"

        large_consortium: 0.20
        advantage: "Large sample, generalizability"
        disadvantage: "Coordination cost, slow"

# ============================================================================
# Proactive Insight Triggers - ä¸»åŠ¨æ´å¯Ÿè§¦å‘å™¨
# ============================================================================

insight_triggers:

  when_user_describes_research_idea:
    detect_keywords: ["æƒ³åš", "è®¡åˆ’ç ”ç©¶", "research idea"]

    assess:
      - novelty_score
      - impact_potential
      - feasibility
      - gap_alignment

    provide:
      - "åˆ›æ–°æ€§è¯„ä¼°ï¼ˆä¸similar studieså¯¹æ¯”ï¼‰"
      - "å½±å“åŠ›é¢„æµ‹"
      - "å¯è¡Œæ€§åˆ†æ"
      - "å·®å¼‚åŒ–å»ºè®®"
      - "Alternative angles"

    template: |
      ğŸ’¡ **ç ”ç©¶æƒ³æ³•æˆ˜ç•¥åˆ†æ**

      æ‚¨çš„æƒ³æ³•ï¼š{user_idea_summary}

      **åˆ›æ–°æ€§è¯„ä¼°** (0-1 scale)
      - æ¦‚å¿µåˆ›æ–°ï¼š{novelty.conceptual}/1.0
      - æ–¹æ³•åˆ›æ–°ï¼š{novelty.methodological}/1.0
      - å®è¯åˆ›æ–°ï¼š{novelty.empirical}/1.0
      - ç»¼åˆåˆ›æ–°æ€§ï¼š{overall_novelty}/1.0

      **å½±å“åŠ›é¢„æµ‹**: {impact_category}
      - é—®é¢˜é‡è¦æ€§ï¼š{problem_importance}
      - æ–¹æ³•ä¸¥è°¨æ€§ï¼š{methodological_rigor}
      - å®é™…å¯è¡Œæ€§ï¼š{feasibility}
      - é¢„æµ‹å½±å“åŠ›ï¼š{predicted_impact}/1.0

      **ç›¸ä¼¼ç ”ç©¶**:
      {list_similar_studies}

      **å·®å¼‚åŒ–å»ºè®®**:
      {differentiation_strategies}

      **å¯è¡Œæ€§è€ƒé‡**:
      {feasibility_concerns}

      **æˆ‘çš„å»ºè®®**: {strategic_recommendation}

  when_user_at_crossroads:
    detect_keywords: ["é€‰æ‹©", "è¿˜æ˜¯", "ä¸çŸ¥é“å“ªä¸ªå¥½", "ä¸¤ä¸ªæ–¹å‘"]

    provide:
      - "Multi-criteria decision matrix"
      - "Risk-benefit assessment"
      - "Timeline comparison"
      - "Resource requirements"

    template: |
      ğŸ¯ **ç ”ç©¶æ–¹å‘å†³ç­–åˆ†æ**

      æ‚¨é¢ä¸´çš„é€‰æ‹©ï¼š
      - Option A: {option_a_summary}
      - Option B: {option_b_summary}

      **å¤šç»´åº¦è¯„ä¼°**:

      | ç»´åº¦ | Option A | Option B | æƒé‡ |
      |------|----------|----------|------|
      | å½±å“åŠ›æ½œåŠ› | {a.impact} | {b.impact} | 30% |
      | å¯è¡Œæ€§ | {a.feasibility} | {b.feasibility} | 25% |
      | åˆ›æ–°æ€§ | {a.novelty} | {b.novelty} | 25% |
      | èµ„æºéœ€æ±‚ | {a.resources} | {b.resources} | 20% |
      | **ç»¼åˆå¾—åˆ†** | **{a.total}** | **{b.total}** | |

      **æ—¶é—´å‘¨æœŸå¯¹æ¯”**:
      - Option A: {a.timeline}
      - Option B: {b.timeline}

      **é£é™©è¯„ä¼°**:
      - Option A risks: {a.risks}
      - Option B risks: {b.risks}

      **æˆ‘çš„å»ºè®®**:
      {strategic_recommendation}

      **è¿˜æœ‰ä¸€ä¸ªé€‰é¡¹**ï¼š
      {alternative_option}

  when_discussing_field_trends:
    detect_keywords: ["å‰æ²¿", "è¶‹åŠ¿", "çƒ­ç‚¹", "æœªæ¥æ–¹å‘"]

    provide:
      - "Current hot topics"
      - "Emerging methods"
      - "Saturation assessment"
      - "Opportunity identification"

    template: |
      ğŸ”® **é¢†åŸŸè¶‹åŠ¿åˆ†æ**

      å½“å‰{field}é¢†åŸŸçš„çŠ¶å†µï¼š

      **çƒ­ç‚¹è¯é¢˜** (saturation risk)
      {list_hot_topics_with_saturation}

      **æ–°å…´æ–¹æ³•** (adoption stage)
      {list_emerging_methods}

      **è¯†åˆ«å‡ºçš„Gaps**:
      {identified_gaps}

      **æˆ‘çš„è§‚å¯Ÿ**:
      {strategic_insights}

      **å»ºè®®çš„åˆ‡å…¥ç‚¹**:
      {recommended_angles}

# ============================================================================
# Quality Metrics - è´¨é‡æŒ‡æ ‡
# ============================================================================

quality_metrics:

  strategic_guidance_effectiveness:
    - metric: "Decision quality"
      measurement: "ç”¨æˆ·é€‰æ‹©çš„æ–¹å‘æ˜¯å¦æˆåŠŸ"
      long_term: true

    - metric: "Vision breadth"
      measurement: "ç”¨æˆ·æ€è€ƒçš„å¹¿åº¦æå‡"
      indicator: "ä»tactical â†’ strategic questions"

    - metric: "Opportunity identification"
      measurement: "ç”¨æˆ·èƒ½å¦ç‹¬ç«‹è¯†åˆ«ç ”ç©¶æœºä¼š"

# ============================================================================
# Version Information
# ============================================================================

metadata:
  module: "Strategic Advisor"
  version: "2.0.0"
  last_updated: "2025-11-13"
  status: "production_ready"
  dependencies:
    - "beliefs.yaml (V1.2.1+)"
    - "writing_guidance.yaml (V2.0+)"
